Vivani Medical (U5P) Stock Statistics & Valuation Metrics
Total Valuation
Vivani Medical has a market cap or net worth of EUR 86.10M. The enterprise value is EUR 105.99M.
- Market Cap
- EUR 86.10M
- Enterprise Value
- EUR 105.99M
Share Statistics
Vivani Medical has 90,203,354 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 90,203,354
- Owned by Insiders
- 50.60%
- Owned by Institutions
- 5.18%
Financial Efficiency
Vivani Medical’s return on equity (ROE) is -1.69 and return on invested capital (ROIC) is -79.68%.
- Return on Equity (ROE)
- -1.69
- Return on Assets (ROA)
- -0.68
- Return on Invested Capital (ROIC)
- -79.68%
- Return on Capital Employed (ROCE)
- -0.84
- Revenue Per Employee
- 0
- Profits Per Employee
- -633.55K
- Employee Count
- 42
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Vivani Medical is -2.97. Vivani Medical’s PEG ratio is -0.12.
- PE Ratio
- -2.97
- PS Ratio
- 0.00
- PB Ratio
- 4.78
- Price to FCF
- -3.54
- Price to Operating Cash Flow
- -3.58
- PEG Ratio
- -0.12
Income Statement
In the last 12 months, Vivani Medical had revenue of 0 and earned -26.61M in profits. Earnings per share was -0.43.
- Revenue
- 0
- Gross Profit
- -424.00K
- Operating Income
- -27.56M
- Pretax Income
- -26.61M
- Net Income
- -26.61M
- EBITDA
- -26.18M
- Earnings Per Share (EPS)
- -0.43
Cash Flow
In the last 12 months, operating cash flow was -25.30M and capital expenditures -1.20M, giving a free cash flow of -26.50M billion.
- Operating Cash Flow
- -25.30M
- Free Cash Flow
- -26.50M
- Free Cash Flow per Share
- -0.30
Dividends & Yields
Vivani Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -27.98%
- Earnings Yield
- -28.77%
Stock Price Statistics
- Beta
- 0.69
- 52-Week Price Change
- -32.17%
- 50-Day Moving Average
- 1.02
- 200-Day Moving Average
- 1.00
- Relative Strength Index (RSI)
- 39.17
- Average Volume (3m)
- 250
Important Dates
Vivani Medical upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
Vivani Medical as a current ratio of 2.71, with Debt / Equity ratio of 119.87%
- Current Ratio
- 2.71
- Quick Ratio
- 2.71
- Debt to Market Cap
- 0.22
- Net Debt to EBITDA
- -0.10
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Vivani Medical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Vivani Medical EV to EBITDA ratio is -3.45, with an EV/FCF ratio of -3.50.
- EV to Sales
- 0.00
- EV to EBITDA
- -3.45
- EV to Free Cash Flow
- -3.50
- EV to Operating Cash Flow
- -3.66
Balance Sheet
Vivani Medical has EUR 19.89M in cash and marketable securities with EUR 17.86M in debt, giving a net cash position of EUR 2.04M billion.
- Cash & Marketable Securities
- EUR 19.89M
- Total Debt
- EUR 17.86M
- Net Cash
- EUR 2.04M
- Net Cash Per Share
- EUR 0.02
- Tangible Book Value Per Share
- EUR 0.22
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Vivani Medical is EUR 3.57, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 3.57
- Price Target Upside
- 307.79% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 24.77%
Scores
- Smart Score
- 3
- AI Score
- ―
